{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,9,23]],"date-time":"2023-09-23T14:20:45Z","timestamp":1695478845779},"reference-count":37,"publisher":"Oxford University Press (OUP)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["QJM"],"published-print":{"date-parts":[[2015,3]]},"DOI":"10.1093\/qjmed\/hcu176","type":"journal-article","created":{"date-parts":[[2014,8,31]],"date-time":"2014-08-31T00:11:29Z","timestamp":1409443889000},"page":"189-196","source":"Crossref","is-referenced-by-count":1,"title":["Bleeding risk, physical functioning and non-use of anticoagulation among patients with stroke and atrial fibrillation"],"prefix":"10.1093","volume":"108","author":[{"given":"A.A.","family":"Schmid","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Ofner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.I.","family":"Shorr","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.S.","family":"Williams","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.M.","family":"Bravata","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2014,8,29]]},"reference":[{"key":"2016040106172488000_108.3.189.1","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.1987.00370090041008"},{"key":"2016040106172488000_108.3.189.2","doi-asserted-by":"publisher","DOI":"10.1159\/000332030"},{"key":"2016040106172488000_108.3.189.3","doi-asserted-by":"publisher","DOI":"10.1159\/000334979"},{"key":"2016040106172488000_108.3.189.4","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-146-12-200706190-00007"},{"key":"2016040106172488000_108.3.189.5","first-page":"2071","article-title":"AHA\/ACC\/HRS Guideline for the management of patients with atrial fibrillation: executive summary","volume":"130","author":"January","year":"2014","journal-title":"J Am Coll Cardiol"},{"key":"2016040106172488000_108.3.189.6","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-151-5-200909010-00003"},{"key":"2016040106172488000_108.3.189.7","doi-asserted-by":"publisher","DOI":"10.1160\/TH09-11-0757"},{"key":"2016040106172488000_108.3.189.8","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.311.6997.83"},{"key":"2016040106172488000_108.3.189.9","doi-asserted-by":"publisher","DOI":"10.1310\/tsr2004-340"},{"key":"2016040106172488000_108.3.189.10","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1682\/JRRD.2012.11.0215","article-title":"Circumstances and consequences of falls among people with chronic stroke","volume":"50","author":"Schmid","year":"2014","journal-title":"J Rehabil Res Develop"},{"key":"2016040106172488000_108.3.189.11","doi-asserted-by":"publisher","DOI":"10.1016\/S0749-0690(02)00013-7"},{"key":"2016040106172488000_108.3.189.12","unstructured":"Bravata DM Ordin DL Vogel B Williams LS . The quality of VA inpatient ischemic stroke care, FY 2007: VHA Office of Quality and Performance (OQP) special study: VHA Office of Quality and Performance and the VA Health Services Research and Development (HSR&D) Quality Enhancement Research Initiative (QUERI). Final national report 2009."},{"key":"2016040106172488000_108.3.189.13","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCOUTCOMES.111.961474"},{"key":"2016040106172488000_108.3.189.14","doi-asserted-by":"publisher","DOI":"10.1016\/0277-9536(89)90309-2"},{"key":"2016040106172488000_108.3.189.15","doi-asserted-by":"publisher","DOI":"10.1067\/mic.2002.125808"},{"key":"2016040106172488000_108.3.189.16","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2702.2002.00578.x"},{"key":"2016040106172488000_108.3.189.17","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-158-5-201303051-00005"},{"key":"2016040106172488000_108.3.189.18","unstructured":"Guide for the Uniform Data Set for Medical Rehabilitation, Version 5.1. Buffalo, NY, State University of New York of Buffalo, 1997."},{"key":"2016040106172488000_108.3.189.19","doi-asserted-by":"publisher","DOI":"10.1097\/00002060-199304000-00005"},{"key":"2016040106172488000_108.3.189.20","doi-asserted-by":"publisher","DOI":"10.1161\/01.STR.31.4.858"},{"key":"2016040106172488000_108.3.189.21","doi-asserted-by":"publisher","DOI":"10.1161\/01.STR.31.4.858"},{"key":"2016040106172488000_108.3.189.22","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.0000145172.55640.93"},{"key":"2016040106172488000_108.3.189.23","doi-asserted-by":"publisher","DOI":"10.1001\/jama.285.22.2864"},{"key":"2016040106172488000_108.3.189.24","unstructured":"Risk of stroke with atrial-fibrillation. 2010. www.cardiology.org\/tools\/risk_of_stroke_AF.html (15 January 2014, date last accessed)."},{"key":"2016040106172488000_108.3.189.25","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjmed.2010.05.007"},{"key":"2016040106172488000_108.3.189.26","doi-asserted-by":"publisher","DOI":"10.1016\/0895-4356(95)00510-2"},{"key":"2016040106172488000_108.3.189.27","doi-asserted-by":"publisher","DOI":"10.1016\/0895-4356(95)00048-8"},{"key":"2016040106172488000_108.3.189.28","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/S0140-6736(89)91200-2","article-title":"Placebo-controlled, randomised trial of warfarin and aspirin for prevention of thromboembolic complications in chronic atrial fibrillation. The Copenhagen AFASAK study","volume":"1","author":"Petersen","year":"1989","journal-title":"Lancet"},{"key":"2016040106172488000_108.3.189.29","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2005.06.077"},{"key":"2016040106172488000_108.3.189.30","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.84.2.527"},{"key":"2016040106172488000_108.3.189.31","doi-asserted-by":"publisher","DOI":"10.1016\/0735-1097(91)90585-W"},{"key":"2016040106172488000_108.3.189.32","doi-asserted-by":"crossref","unstructured":"The effect of low-dose warfarin on the risk of stroke in patients with nonrheumatic atrial fibrillation. The Boston area anticoagulation trial for atrial fibrillation investigators. N Engl J Med. 1990; 323:1505\u201311.","DOI":"10.1056\/NEJM199011293232201"},{"key":"2016040106172488000_108.3.189.33","first-page":"1255","article-title":"EAFT (European atrial fibrillation trial) study group","volume":"342","author":"Koudstaal","year":"1993","journal-title":"Lancet"},{"key":"2016040106172488000_108.3.189.34","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCOUTCOMES.111.961755"},{"key":"2016040106172488000_108.3.189.35","doi-asserted-by":"publisher","DOI":"10.1053\/apmr.2000.6981"},{"key":"2016040106172488000_108.3.189.36","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2012.06.019"},{"key":"2016040106172488000_108.3.189.37","doi-asserted-by":"publisher","DOI":"10.1378\/chest.1412S3"}],"container-title":["QJM"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/qjmed\/article-pdf\/108\/3\/189\/5312378\/hcu176.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,8,24]],"date-time":"2017-08-24T08:22:42Z","timestamp":1503562962000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/qjmed\/article-lookup\/doi\/10.1093\/qjmed\/hcu176"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,8,29]]},"references-count":37,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2015,2,23]]},"published-print":{"date-parts":[[2015,3]]}},"alternative-id":["10.1093\/qjmed\/hcu176"],"URL":"https:\/\/doi.org\/10.1093\/qjmed\/hcu176","relation":{},"ISSN":["1460-2725","1460-2393"],"issn-type":[{"value":"1460-2725","type":"print"},{"value":"1460-2393","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,8,29]]}}}